Elevated liver enzymes often pose a diagnostic dilemma for clinicians, due to their non-specific nature and wide array of potential etiologies. This article aims to provide a comprehensive approach to decipher this clinical conundrum.
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are the most commonly assessed liver enzymes. Their elevation is suggestive of hepatocellular injury. However, the degree of elevation does not necessarily correlate with the severity of liver damage.
Common causes include viral hepatitis, alcohol-related liver disease, non-alcoholic fatty liver disease, and drug-induced liver injury. Less common causes include autoimmune hepatitis, hemochromatosis, Wilson's disease, and alpha-1 antitrypsin deficiency.
A thorough history and physical examination should be the initial step. If the cause is not apparent, a systematic approach should be adopted. This includes ruling out common causes first, followed by screening for less common causes if initial investigations are inconclusive. Imaging studies and liver biopsy may be required in certain situations.
Management largely depends on the underlying cause. Lifestyle modifications and abstinence from alcohol are often recommended. Regular follow-up with liver function tests is essential to monitor response to treatment and progression of disease. In cases of persistent unexplained elevation, referral to a hepatologist may be necessary.
Elevated liver enzymes present a diagnostic challenge due to the broad differential diagnosis. A systematic and comprehensive approach can help clinicians in making an accurate diagnosis and initiating appropriate management. Continuous medical education and staying updated with the latest research are key to overcoming this diagnostic dilemma.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation